A2AR limits IL-15-induced generation of CD39+ NK cells with high cytotoxicity

Int Immunopharmacol. 2023 Jan:114:109567. doi: 10.1016/j.intimp.2022.109567. Epub 2022 Dec 16.

Abstract

CD39-mediated inhibition of natural killer (NK) cell activity has been demonstrated, but the characteristics of CD39+ NK cells in humans are not known. We investigated the characteristics of human circulating CD39+ NK cells. In healthy donors, the proportion of circulating CD39+ NK cells in total NK cells was relatively low compared with that of CD39- NK cells. Nonetheless, a higher proportion of CD39+ NK cells expressed CD107a. Similarly, a higher proportion of CD39+ NK cells expressed CD107a in patients with hepatitis B virus or patients with hepatocellular carcinoma. Stimulation with NK-sensitive K562 cells or interleukin (IL)-12/IL-18 activated CD39+ NK cells to express higher levels of CD107a, IFN-γ and TNF-α, relative to CD39- NK cells. Importantly, IL-15 induced the generation of CD39+ NK cells. In contrast, A2A adenosine receptor (A2AR) ligation suppressed the generation of CD39+ NK cells by inhibiting IL-15 signaling. These data for the first time demonstrated that A2AR counteracts IL-15-induced generation of human CD39+ NK cells, which have a stronger cytotoxicity than CD39- NK cells. IL-15-induced human CD39+ NK cells might be better choice for immunotherapy based on adoptive transfer of NK cells.

Keywords: A2A adenosine receptor; CD39; Cytotoxicity; IL-15; NK cells.

MeSH terms

  • Cytotoxicity, Immunologic
  • Humans
  • Interleukin-15*
  • Killer Cells, Natural*
  • Receptor, Adenosine A2A / metabolism

Substances

  • Interleukin-15
  • Receptor, Adenosine A2A